Clomiphene and dexamethasone boost fertility in PCOS patients

FHS
May 23, 2024
3:21 am

Combined clomiphene and dexamethasone treatment improves pregnancy and ovulation rates in PCOS patients, with minimal adverse effects. Further research is needed to optimize dosage and duration.

Mirum’s maralixibat oral secures approval from Health Canada

LIVMARLI has been now authorised in Canada to treat cholestatic pruritus in patients with Alagille syndrome. Credit: Shidlovski /Shutterstock.com. Mirum Pharmaceuticals has received approval from

July 26, 2023

Advancing quality integrated health services through relational community engagement

A new report, entitled “Relationality in community engagement: its role in humanizing healthcare and achieving quality integrated health Services” has been developed in collaboration with

December 22, 2024

Opinion | AI Can Play a Role in Reducing Stroke Disparities

Etienne is a neurologist. I recently evaluated one of my patients who had a stroke 2 years ago. After his stroke, we did an extensive

July 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.